Connection
Douglas Osborne to CTLA-4 Antigen
This is a "connection" page, showing publications Douglas Osborne has written about CTLA-4 Antigen.
|
|
Connection Strength |
|
 |
|
 |
|
0.053 |
|
|
|
-
Vaddi PK, Osborne DG, Nicklawsky A, Williams NK, Menon DR, Smith D, Mayer J, Reid A, Domenico J, Nguyen GH, Robinson WA, Ziman M, Gao D, Zhai Z, Fujita M. CTLA4 mRNA is downregulated by miR-155 in regulatory T cells, and reduced blood CTLA4 levels are associated with poor prognosis in metastatic melanoma patients. Front Immunol. 2023; 14:1173035.
Score: 0.053